Market Playground

By Chris Rees

Hutchinson Technology Incorporated (NASDAQ:HTCH), a portfolio holding and turnaround candidate, is in trouble. I originally expected the company to get back to break-even by next June, but that now looks unlikely.

Hutchinson was in the process of moving manufacturing from the U.S. to Thailand to lower costs and be closer to their customers. Their brand new Thai factory is now under water due to the nationwide flooding. With Thailand operations shut down, HTCH is ramping production in the U.S. Flood waters are receding but it will be multiple quarters before HTCH can get back on track. In the meantime, operating losses will continue. The runway for a successful HTCH recovery is now significantly shorter due to the Thai flood disaster. It will bear close watching. Meanwhile, I assess that HTCH is priced at about an 80% discount to its book value of near $9.

While the news was bad at HTCH, no news was good news at AVEO Pharmaceuticals (NASDAQ:AVEO), another portfolio holding. They announced trial results for Tivozanib, their RCC cancer drug, would not be released until early next year. This is good news. It implies Progression Free Survival (PFS) will exceed both Nexavar and Sutent with a better side effect profile.

After becoming fully invested in August, we trimmed market exposure in late October as the European debt crisis worsened. We sold Ensco PLC (NYSE:ESV) and Total (NYSE:TOT) and booked profits in both.

As of 11/4, we are now 17% in cash. Given the abundant stresses in world markets, we feel more comfortable moving back to a more defensive stance.

Disclosure: Long HTCH, AVEO

The above article comes from Covestor. For more information on Chris Rees and  TenStocks and to view his Covestor Model, visit Covestor.com. 

Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model Managers to establish investment models. The commentary here is provided as general and impersonal information and should not be construed as recommendations or advice. Information from Model Managers and third-party sources deemed to be reliable but not guaranteed. Past performance is no guarantee of future results. Transaction histories for Covestor models available upon request. Additional important disclosures available at http://site.covestor.com/help/disclosures. For information about Covestor and its services, go to http://covestor.com or contact Covestor Client Services at (866) 825-3005, x703.